With the help of an AI tool, computed tomography (CT) scans taken originally to look for tumors or bleeding or infections, also revealed calcium buildup in arteries, a sign of worsening cardiovascular ...
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system (CNS) and metabolic disorders. Relmada’s experienced and dedicated team is committed to ...
Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. | Profound Medical CEO Arun Menawat discusses TULSA-PRO, an innovative technology for treating ...